GENE ONLINE|News &
Nionyx Bio Wins 2026 BIO-Europe Spring Startup Spotlight for Kidney Gene Therapy
Nionyx Bio has secured first place in the 2026 BIO-Europe Spring Startup Spotlight competition held in Lisbon. The biotechnology company, led by CEO Magdalena Tyrpien, was recognized for its innovative kidney gene therapy, which aims to address unmet medical needs in nephrology. The award highlights Nionyx Bio’s contributions to advancing therapeutic solutions within the biotech industry.
The annual BIO-Europe Spring event serves as a platform for emerging companies to showcase their technologies and compete for recognition among industry leaders. Nionyx Bio’s achievement underscores the growing interest in gene therapy approaches for treating kidney-related conditions. The company’s win reflects its commitment to developing cutting-edge treatments and positions it as a notable player in the field of biotechnology.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 2, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Italian Biodiversity Study Identifies Plant-Based Compounds with Potential Neuroprotective Benefits
2026-04-15
Researchers Develop Integrated Photo-Biocatalysis System Using Visible Light for Sustainable Chemical Synthesis
2026-04-15
Study Explores Stability and Health Benefits of Postbiotics and Paraprobiotics in Functional Foods
2026-04-15
PSA Singapore Adopts Motorola Solutions Technology to Enhance Port Communication and Safety
2026-04-15
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
